Triple-Action Antifungal Topicals, Microbiologist's Alarm
Asian Journal of Biology · pp. 37–44 · Published 4 Aug 2023
10.9734/ajob/2023/v19i1357Abstract
Today, we are witnessing the development and marketing of triple action antifungals for the treatment of superficial mycoses. It is a mixture of antifungals, antibiotics and anti-inflammatory. The problem of this research was to verify the effects of this mixture as to its effectiveness on superficial mycoses. Thus, we set ourselves the following objectives: to identify the antifungals in the pharmacies of the cities of Likasi, Lubumbashi and Kolwezi, to determine their composition and to discuss this composition with the existing literature. Through a cross-sectional study, we identified thirty-four different antifungals in 588 pharmacies, of which 16 or 47.05% are triple action and made up of Azoles as antifungal, the antibiotic gentamicin, and corticosteroids as anti-inflammatory, alongside polyene, Echinocandins and flucytosine. It is the combination of antifungals with conventional non-antifungal agents reoriented for their action on the growth of fungi. They consist of antibacterial drugs and steroidal anti-inflammatories. This reorientation was supposed to have excellent antifungal activity and could prevent resistance. However, the presence of the antibiotic will reduce the composition of the colonizing microbiota and promote fungal growth and enhance fungal pathogenicity indirectly and the corticosteroid component may interfere with the therapeutic actions of the antifungal agent and may accelerate fungal growth, due to a decrease in the host's local immunological reaction, so that the underlying infection may persist, and the dermatophytes may even acquire the ability to invade the deeper tissues. So, in support, it would be interesting to favor antifungals without combinations than those combining antibiotics and anti-inflammatory which has an extremely high rate of recurrence.
References (33)
- 1 Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions [DOI]
- 2 Candida auris: Epidemiology, biology, antifungal resistance, and virulence [DOI]
- 3 Amphotericin forms an extramembranous and fungicidal sterol sponge [DOI]
- 4 Molecular Evolution of Antifungal Drug Resistance [DOI]
- 5 Commensal Fungi in Health and Disease [DOI]
- 6 Clinical implications of globally emerging azole resistance in Aspergillus fumigatus [DOI]
- 7 Antifungal Drugs: The Current Armamentarium and Development of New Agents [DOI]
- 8 The Fungal Mycobiome and Its Interaction with Gut Bacteria in the Host [DOI]
- 9 The antifungal arsenal: alternative drugs and future targets [DOI]
- 10 An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy [DOI]
- 11 Drug repurposing strategies in the development of potential antifungal agents [DOI]
- 12 Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi [DOI]
- 13 Emerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations [DOI]
- 14 Calling upon all public health mycologists [DOI]
- 15 The effect of antibacterial and non-antibacterial compounds alone or associated with antifugals upon fungi [DOI]
- 16 Repurposing the Clinically Efficacious Antifungal Agent Itraconazole as an Anticancer Chemotherapeutic [DOI]
- 17 Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis [DOI]
- 18 Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies [DOI]
- 19 Antibacterial to antifungal conversion of neamine aminoglycosides through alkyl modification. Strategy for reviving old drugs into agrofungicides [DOI]
- 20 New developments and directions in the clinical application of the echinocandins [DOI]
- 21 Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease [DOI]
- 22 Role of Education in Antimicrobial Stewardship [DOI]
- 23 Limited Activity of Miltefosine in Murine Models of Cryptococcal Meningoencephalitis and Disseminated Cryptococcosis [DOI]
- 24 Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence [DOI]
- 25 Medication Safety in Clinical Trials: Role of the Pharmacist in Optimizing Practice, Collaboration, and Education to Reduce Errors.
- 26 Nano-Vesicle Based Anti-Fungal Formulation Shows Higher Stability, Skin Diffusion, Biosafety and Anti-Fungal Efficacy In Vitro [DOI]
- 27 How We Approach Combination Antifungal Therapy for Invasive Aspergillosis and Mucormycosis in Transplant Recipients [DOI]
- 28 The Role of Antimicrobial Stewardship in the Clinical Microbiology Laboratory: Stepping Up to the Plate [DOI]
- 29 Antifungal Activity of Gentamicin B1 against Systemic Plant Mycoses [DOI]
- 30 Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis [DOI]
- 31 Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis [DOI]
- 32 Improper Use of Topical Corticosteroids in Tinea Infections in a Tertiary Care Hospital [DOI]
- 33 Retrospective evaluation of in vitro effect of gentamicin B1 against Fusarium species [DOI]
Cited by 0
No indexed citations yet.
Related research
- Antimicrobial Assessment of Annona muricata Fruits and Its Chemical Compositions — shares topic coverage
- Antimicrobial Activity, Phytochemical Screening and Nutrient Analysis of Tetrapleura tetraptera and Piper guineense — shares topic coverage
- Antifungal Susceptibility Pattern in Otomycosis among Patients Attending a Tertiary Healthcare Institution in Port Harcourt, Nigeria — shares topic coverage
- Evaluation of In-vitro Anti-Inflammatory, Anti-Fungal, Thrombolytic, Membrane Stabilizing and Cytotoxic Properties of (Camellia chrysantha Hu Tuyama) — shares topic coverage
- Design, Development, and Characterization of Luliconazole-loaded Bilosomal Gel for Enhanced Cutaneous Delivery — shares topic coverage
Article metrics
Real usage data collected on this platform.
9
Page views
0
PDF downloads
1
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.